Maxcyte ExPERT STx Flow Electroporation Platform Generation 3 System
Posted Date:
Jun 21, 2024
Due Date:
Jul 11, 2024
Awarded Date:
No Awarded Date
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| NOI-NIAID-24-2224326 | Maxcyte ExPERT STx Flow Electroporation Platform Generation 3 System | |
| Synopsis | ||
|
PRE-SOLICITATION NOTICE **NOTICE OF INTENT NOI-NIAID-24-2224326 NAICS – 334516 This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with MaxCyte Inc to procure a Maxcyte ExPERT STx Flow Electroporation Platform Generation 3 system. Maxcyte will provide a one-year warranty, technical support, installation, training, and ongoing technical assistance. The Cell Line Development Team at the Vaccine Production Program (VPP) of the Vaccine Research Center (VRC) is responsible .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
